Canopy Rivers (TSX: RIV) (OTC: CNPOF) has set a filing date for its Q2 2021 financial results. The company plans to release its Q2 FY 2021 financial report on Nov. 9, 2020, before the market…
Cybin Corp., a Canada-based, life-science company advancing psychedelic pharmaceuticals, recently announced the appointment of Doug Drysdale as its CEO (https://ibn.fm/UTTdr). Drysdale, named an Ernst and Young Entrepreneur of the Year in 2012, brings more than…
Processa Pharmaceuticals (NASDAQ: PCSA) is a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options. A recent article discussing the company…
Backed by an anonymous donor, Berkeley launches a center for psychedelic science and public education Berkley follows examples of other notable universities such as Johns Hopkins in Maryland, Imperial College in London, and Canadian Centre…
Knightscope recently named Ms. Mallorie Burak as Executive Vice President and Chief Financial Officer The company’s autonomous security robots use proprietary technology, combining robotics, self-driving capabilities, and artificial intelligence Game changing technology has now been…
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, earlier this year announced the closing of a private placement financing (the “offering”). According to the update, AzurRx secured…
Study results have exciting therapeutic potential across wide range of CNS indications. VTGN focused on developing new generation of medications to treat anxiety, depression and more. Company committed to finding treatment to help estimated 264…
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous robots focused on enhancing U.S. security operations, recently announced its receipt of a purchase order from a California Water District to help protect the…
Houston-based CNS Pharmaceuticals is preparing to launch Phase 2 clinical testing of a novel brain cancer-fighting drug candidate called Berubicin early next year The biopharmaceutical company recently announced that a U.S.-based company contracted to make…
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of uranium in the United States, on Friday reported its financial results for the quarter ended September 30, 2020. In addition, Energy Fuels will host…
Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, announced receipt of new and repeat domestic orders for BolaWrap(R) products and accessories. According to the update, the company has received numerous recent orders from…